Meclofenamate Sodium(CAS: 6385-02-0)

Meclofenamate Sodium (CAS: 6385-02-0) must comply with various regulatory guidelines. In the European Union, it falls under REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) regulations. For the United States, it is regulated by the EPA and FDA. It is classified as a drug substance according to the GHS (Globally Harmonized System of Classification and Labelling of Chemicals) and requires appropriate safety data sheets (SDS) and labels.

Yes, there are alternatives to Meclofenamate Sodium in synthesis. Common analogs include ibuprofen and diclofenac. Alternative reagents that can be used in its synthesis include 2-(4-chlorobenzoyl)phenylacetic acid, which can serve as a starting material. Isomers such as the racemic form can also be utilized in certain processes.

Research and market trends for Meclofenamate Sodium (CAS: 6385-02-0) indicate a focus on its anti-inflammatory and analgesic properties. Recent studies are exploring its potential in combination therapies. Market trends show increasing demand, driven by its effectiveness in treating musculoskeletal pain. However, ongoing research is also investigating possible alternatives and new formulations.

Waste containing Meclofenamate Sodium (CAS: 6385-02-0) should be handled according to environmental protection guidelines. Waste liquids should be collected in appropriate containers and neutralized if necessary. Incineration or professional waste disposal services are recommended. Precautions include ensuring the waste is not released into the environment and that all safety protocols are followed during handling and disposal.